FDA Inspection
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.Livzon Group (Ningxia) Pharmaceutical Co., Ltd. – FDA Inspection, Oct 19, 2018
Record Details
This FDA Inspection record concerns Livzon Group (Ningxia) Pharmaceutical Co., Ltd., with an inspection on October 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 19, 2018
- Product Type
- Drugs
View Company Profile
ID · a82b46fe-c65c-416b-a72d-567fb166f2f3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1070291
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 13, 2017 | VAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
- FDA Inspection 1286526 - 2025-09-05
- FDA Inspection 1115730 - 2019-12-06
- FDA Inspection 998978 - 2017-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.